- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04243759
Inhibitory Control Smartphone App
A Smartphone App to Capture Inhibitory Control as a Novel Moderate Drinking Tool for Young Adults
Study Overview
Status
Conditions
Detailed Description
An app giving in-the-moment feedback could increase perceived impairment, and reduce drinking and consequences.
The cued go/no-go (CGNG) task is an ideal choice for in-the-moment impairment feedback. Its instructions are simple; practice effects are minimal; and is sensitive to alcohol. The CGNG tests ability to respond fast to "go" targets (activation) while withholding response to "no-go" targets (inhibition). Activation/inhibition tension is externally valid. Dual process models posit risk behaviors stem from overactive appetitive drives that are compelling and hard to inhibit. Poor CGNG performance post-alcohol has been related to poor simulated driving, enhancing external validity. Moderate dosing to .05-.06% blood alcohol content (BAC) reliably increases inhibition errors, but slowing reaction time (RT) to "go" cues requires higher doses. RT to go cues often recovers later in a drinking episode (acute tolerance) but ability to inhibit does not. Thus at this BAC, ability to respond remains but inhibition is impaired, which relates to risk behaviors like DUI as young adults underrate impairment.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Florida
-
Gainesville, Florida, United States, 32610
- UF Health at the University of Florida
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Be able to read English and complete study evaluations
- Report drinking to an estimated blood alcohol concentration (eBAC) of 0.12% (i.e., the maximum allowable BAC in the alcohol drinking sessions in this study) or higher at least once in the prior 30 days
- Report at least four days with heavy episodic drinking (i.e., 4 or more drinks for women and 5 or more drinks for men) out of the prior 30 days
- Report having consumed at least one alcoholic drink during a minimum of 12 days out of the prior 30 in order to maximize the likelihood that subjects will choose to drink during the self-administration portion of the laboratory sessions.
- Meet, at minimum, DSM-5 criteria for a mild alcohol use disorder (i.e., meet at least 2 diagnostic criteria)
- Perform within 2 standard deviations of normative levels both with regard to reaction time and number of errors on the cued go/no-go task at in-person screening
- Have an iphone/iOS-compatible phone that they are willing to use for study-related tasks (field use-only participants from outside of the Gainesville area, only; local participants will have an opportunity to borrow a study phone)
Exclusion Criteria:
- Be seeking treatment for alcohol or other addictive behaviors or have been in inpatient or intensive outpatient treatment within the past 12 months
- Have used a smartphone application to facilitate moderate drinking more than 1 time within the past 12 months
- Provide two positive breath alcohol concentration (BrAC) readings (i.e., > 0.00%) at an in-person screening appointment or on the day of the alcohol drinking session. After participants blow their first positive BrAC, they will be allowed to reschedule and participate at another time, however if they blow a second positive BrAC, they will be excluded from this study and offered referrals for alcohol treatment.
- Have positive urine screen results at the in-person screening or on the day of an alcohol drinking session for opiates, cocaine, phencyclidine, amphetamines, methamphetamine, barbiturates, methadone or benzodiazepines.
- Meet criteria for current nicotine dependence or dependence on any other drug, excluding alcohol.
- Report current use of psychotropic drugs including anxiolytics and antidepressants.
- Have received a prescription for any psychotropic drug in the 30 days prior to study enrollment
- Be psychotic or otherwise severely psychiatrically disabled
- Report a history of a medical condition that would contraindicate the consumption of alcohol (e.g., liver disease, cardiac abnormality, pancreatitis, diabetes, neurological problems, and gastrointestinal disorders).
- Have a history of clinically significant withdrawal from alcohol, defined as any one of the following: a) a lifetime history of seizures, delirium, or hallucinations during alcohol withdrawal; b) a Clinical Institute Withdrawal Assessment scale (CIWA-Ar, Sullivan et al., 1989) score > 8; c) a report of drinking to avoid withdrawal symptoms in the past 12 months; or d) a lifetime history of medical treatment for withdrawal.
- A woman who is pregnant, nursing, or refuses to use a reliable method of birth control.
- Report disliking vodka or vodka mixed drinks. Vodka is the alcoholic beverage participants to be used in the proposed study
- Body weight less than 110 pounds or greater than 220 pounds
- Be colorblind
- Be a Foreign National
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Control App Group
Young Adult Drinkers will be randomized to 1 of the 3 app conditions (Control App Version; Standard App Version; Experimental, Feedback App Version).
The apps will be tested both during a laboratory alcohol drinking session and a 4-week period outside the lab in which they can use this technology in actual drinking situations.
For the 4-week period outside the lab, all participants will use the experimental app for 2 weeks in real drinking occasions and not use it the other 2 weeks.
|
The control version is a smartphone-compatible CGNG.
The cued go/no-go (CGNG) tests ability to respond fast to "go" targets (activation) while withholding response to "no-go" targets (inhibition).
The experimental, feedback version includes the standard plus feedback on RT and inhibition errors compared to pre-drinking.
The app will state that there are simple alternatives with invitation to press a box to view advice, based on research that risk information may increase risky behavior if convenient options are not given73.
Feedback will be worded non-judgmentally per motivational interviewing tenets.
|
|
Experimental: Standard App Group
Young Adult Drinkers will be randomized to 1 of the 3 app conditions (Control App Version; Standard App Version; Experimental, Feedback App Version).
The apps will be tested both during a laboratory alcohol drinking session and a 4-week period outside the lab in which they can use this technology in actual drinking situations.
For the 4-week period outside the lab, all participants will use the experimental app for 2 weeks in real drinking occasions and not use it the other 2 weeks.
|
The experimental, feedback version includes the standard plus feedback on RT and inhibition errors compared to pre-drinking.
The app will state that there are simple alternatives with invitation to press a box to view advice, based on research that risk information may increase risky behavior if convenient options are not given73.
Feedback will be worded non-judgmentally per motivational interviewing tenets.
The standard version is the same as the control version with the exception that information about performance (correct or incorrect) is displayed along with RT in ms for a correct response during each inter-trial interval.
|
|
Experimental: Experimental, Feedback App Group
Young Adult Drinkers will be randomized to 1 of the 3 app conditions (Control App Version; Standard App Version; Experimental, Feedback App Version).
The apps will be tested both during a laboratory alcohol drinking session and a 4-week period outside the lab in which they can use this technology in actual drinking situations.
For the 4-week period outside the lab, all participants will use the experimental app for 2 weeks in real drinking occasions and not use it the other 2 weeks.
|
The experimental, feedback version includes the standard plus feedback on RT and inhibition errors compared to pre-drinking.
The app will state that there are simple alternatives with invitation to press a box to view advice, based on research that risk information may increase risky behavior if convenient options are not given73.
Feedback will be worded non-judgmentally per motivational interviewing tenets.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Alcoholic Drinks Intended to Consume if They Were Free (i.e., Intensity)
Time Frame: Day 1
|
Number of alcoholic drinks participants report an intention to consume at no cost on the state version of the Alcohol Purchase Task following alcohol administration in the lab.
The State Version of the Alcohol Purchase Task is a behavioral economic measure capturing number of drinks participants report an intention to consume now at different price points, provided they were able to drink.
Hypothetical costs range from free to $15 each.
Higher numbers of self-reported, intended drinks indicates greater motivation to consume alcohol.
At each price point, number of drinks can range from 0 to 25.
The Alcohol Purchase Task yields several variables, but in this outcome, we considered only intensity, i.e., number of drinks one reports they would have if they were free.
|
Day 1
|
|
Change in Number of Alcoholic Drinks Consumed Per Occasion
Time Frame: Two weeks with full app access versus two weeks without during the 4-week field use period
|
Entails comparisons of alcoholic drinks consumed per occasion between the 2 weeks participants had full app access vs. the 2 weeks they did not have full app access during the 4-week field use period after the alcohol drinking session.
|
Two weeks with full app access versus two weeks without during the 4-week field use period
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Liana Hone, MS, MPH, PHD, University of Florida
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB202001530
- R21AA026918 (U.S. NIH Grant/Contract)
- IRB201801604 - N (Other Identifier: UF IRB)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Drinking Behavior
-
Penn State UniversityNot yet recruiting
-
Penn State UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institutes...TerminatedUnderage Drinking | Driving Under the Influence | Drinking, Teen | Drinking, CollegeUnited States
-
Yonsei UniversityBlueSignum CorporationRecruitingAlcohol Drinking | High-Risk Drinking PatternsSouth Korea
-
Brown UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Active, not recruitingAlcohol Drinking | Youth DrinkingUnited States
-
University of WyomingRecruitingAlcohol Drinking | CravingUnited States
-
Auburn UniversityNot yet recruiting
-
University of North Carolina, Chapel HillNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedDrinking Behavior | Adolescent Behavior | Drinking, Alcohol | Alcohol Drinking, AdolescentUnited States
-
Loyola Marymount UniversityCompletedUnderage DrinkingUnited States
-
Loyola Marymount UniversityCompleted
-
The University of Hong KongRecruiting
Clinical Trials on Control App Version
-
NYU Langone HealthNational Institutes of Health (NIH)Recruiting
-
Stanford UniversityWalking on Earth Ltd.Not yet recruitingMental Well-being | Resilience, PsychologicalUnited States
-
icometrixBristol-Myers SquibbCompletedMultiple SclerosisBelgium, United States, Germany
-
VA Palo Alto Health Care SystemCompletedStress Disorders, Post-TraumaticUnited States
-
University of ParmaCompletedInflammatory Response | Endotoxemia | Oxidative Stress | Glucose, High BloodItaly
-
University of MichiganNational Institute on Minority Health and Health Disparities (NIMHD)CompletedHealthy | Overweight | ObeseUnited States
-
Chulalongkorn UniversityRecruitingDiabetes Complications | Neuropathic Pain | Type 2 Diabetes Mellitus (T2DM) | Type 1 Diabetes Mellitus (T1DM) | Diabetic Neuropathy, Distal Symmetric Polyneuropathy (Manifestation) | Painful Diabetic Neuropathy (PDN)Thailand
-
University of OxfordLupina FoundationCompleted
-
Jordan University of Science and TechnologyCompletedLow Back PainJordan